Just a moment...
Convert scanned orders, printed notices, PDFs and images into clean, searchable, editable text within seconds. Starting at 2 Credits/page
Try Now →Press 'Enter' to add multiple search terms. Rules for Better Search
Use comma for multiple locations.
---------------- For section wise search only -----------------
Accuracy Level ~ 90%
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
No Folders have been created
Are you sure you want to delete "My most important" ?
NOTE:
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
Don't have an account? Register Here
Press 'Enter' after typing page number.
Issues: Whether the appellant was entitled to discharge or quashing at the pre-trial stage in a prosecution under the Narcotic Drugs and Psychotropic Substances Act, and whether the materials collected during further investigation were sufficient to justify framing of charge under Section 29 read with Section 23 of that Act.
Analysis: At the stage of framing charge, the court is not required to weigh the probative value of the evidence as if conducting a trial. If the materials on record make the commission of the offence a probable consequence, or create a reasonable basis to think that the accused might have committed the offence, a charge can be framed. The materials relied on by the prosecution, including the alleged role of the appellant in the export chain, the fictitious nature of the consignor and consignee, the alleged link with the clearing agency, and the identification material collected during investigation, were sufficient to justify proceeding to trial. The plea based on the absence of sanction under Section 188 of the Code of Criminal Procedure was not pursued. The court also held that the photograph-based identification material could be considered at the investigative stage, though substantive proof would arise only from in-court identification.
Conclusion: The plea for discharge failed, and the order directing the appellant to face trial under Section 29 read with Section 23 of the Narcotic Drugs and Psychotropic Substances Act was upheld.